Licensing Agreements

Bayer Schering to develop new imaging compounds to detect neurodegenerative diseases

Published in Healthcare Mergers, Acquisitions and Ventures Week, February 24th, 2007

Bayer Schering Pharma AG (SHR) has signed a license and option agreement with Taisho Pharmaceutical Co., Ltd., Nihon Nohyaku Co., Ltd., and the National Institute of Radiological Sciences (NIRS), Japan, to develop novel imaging compounds for the detection of neurodegenerative diseases such as Alzheimer disease, Parkinson disease and other disorders also associated with neuroinflammation such as multiple sclerosis.

"We are convinced that innovations in molecular imaging have the potential to fundamentally improve the diagnosis of neurodegenerative disorders, particularly Alzheimer's disease. Bayer Schering Pharma is already pursuing the development of tracers targeting...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week

Source: Healthcare Mergers, Acquisitions and Ventures Week (2007-02-24)

More Articles from Healthcare Mergers, Acquisitions and Ventures Week

Abdominal Aortic Aneurysms
Stanford researchers launch study on effects of exercise on abdominal aneurysms
Accreditation
Healthways receives NCQA full accreditation for depression and oncology
Accreditation
Humana Military Healthcare Services receives URAC HIPAA Privacy Accreditation
Actinic Keratoses
International guidelines recommend PDT as first-line treatment for actinic keratoses
Addiction Medicine
Ortho-Clinical Diagnostics offers complete drugs-of-abuse panel, adds five assays
Addiction Medicine
Ovation, National Institute on Drug Abuse study vigabatrin in cocaine addiction
More from this issue of Healthcare Mergers, Acquisitions and Ventures Week

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry